StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly total equity ($M) ($M)

Form 10-Q / 10-K Consolidated Balance Sheets (Postgres DB)

Latest, FY2025
26,535
Period ended Dec 31, 2025
Change on a year earlier
+85.9%
14,272 in FY2024
History
18 years
Since FY2008
Sources
14
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal equity ($M) ($M)Year on yearSource
FY2025Dec 31, 202526,535+85.9%Form 10-K (filed 2026-02-12) ↗
FY2024Dec 31, 202414,272+31.4%Form 10-K (filed 2026-02-12) ↗
FY2023Dec 31, 202310,864+0.8%Form 10-K (filed 2024-02-21) ↗
FY2022Dec 31, 202210,775+17.7%Form 10-K (filed 2023-02-22) ↗
FY2021Dec 31, 20219,155+57.2%Form 10-K (filed 2022-02-23) ↗
FY2020Dec 31, 20205,825+115.8%Form 10-K (filed 2021-02-17) ↗
FY2019Dec 31, 20192,699-75.3%Form 10-K (filed 2020-02-19) ↗
FY2018Dec 31, 201810,909-6.5%Form 10-K (filed 2019-02-19) ↗
FY2017Dec 31, 201711,668-17.1%Form 10-K (filed 2018-02-20) ↗
FY2016Dec 31, 201614,081-3.4%Form 10-K (filed 2017-02-21) ↗
FY2015Dec 31, 201514,571-5.2%Form 10-K (filed 2018-02-20) ↗
FY2014Dec 31, 201415,373-12.8%Form 10-K (filed 2017-02-21) ↗
FY2013Dec 31, 201317,631+19.4%Form 10-K (filed 2016-02-19) ↗
FY2012Dec 31, 201214,765+9.0%Form 10-K (filed 2015-02-19) ↗
FY2011Dec 31, 201113,542+9.0%Form 10-K (filed 2014-02-19) ↗
FY2010Dec 31, 201012,420+30.4%Form 10-K (filed 2014-02-19) ↗

Breakdown

What makes up total equity ($m)

Cite this data

StockData. (2026). Eli Lilly Total equity ($M) ($M), annual FY2008–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_eq

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.